Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 713   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


New drug discovery: Where are we heading to?

Yadav M R

Year : 2013| Volume: 4| Issue : 1 | Page no: 2-3

   This article has been cited by
1 3D-QSAR, drug-likeness, ADMET prediction, and molecular docking studies in silico of novel 5-oxo-1-thioxo-4,5-dihydro-1H-thiazolo[3,4-a]quinazoline derivatives as MALT1 protease inhibitors for the treatment of B cell lymphoma
Rachid Haloui, Ossama Daoui, Khaoula Mkhayar, Mohamed El Yaqoubi, Souad Elkhattabi, Amal Haoudi, Youssef Kandri Rodi, Fouad Chahdi Ouazzani, Samir Chtita
Chemical Papers. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 QSAR and molecular docking study of quinazoline derivatives as anticancer agents using molecular descriptors
R. Kasmi,E. Hadaji,M. Bouachrine,A. Ouammou
Materials Today: Proceedings. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 QSAR modeling, molecular docking studies and ADMET prediction on a series of phenylaminopyrimidine-(thio) urea derivatives as CK2 inhibitors
Amina Goudzal,Abdellah El Aissouq,Hicham El Hamdani,Abdelkrim Ouammou
Materials Today: Proceedings. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Synthesis of Some New Pyrazolone-Based Heterocycles Containing Sulphone Moiety Acting as a-Glucosidase and a-Amylase Inhibitors
Taha M. A. Eldebss,Ahmad M. Farag,Mohamed M. Abdalla,Ahmad A. Khedr
Journal of Heterocyclic Chemistry. 2019;
[Pubmed]  [Google Scholar] [DOI]


Read this article